(3-{2-[(4-Fluorophenyl)sulfonyl]benzyl}-4-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-imidazol-1-yl)acetic acid

ID: ALA3775455

Chembl Id: CHEMBL3775455

PubChem CID: 127032357

Max Phase: Preclinical

Molecular Formula: C25H21FN2O5S

Molecular Weight: 480.52

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1c(-c2ccccc2)n(CC(=O)O)c(=O)n1Cc1ccccc1S(=O)(=O)c1ccc(F)cc1

Standard InChI:  InChI=1S/C25H21FN2O5S/c1-17-24(18-7-3-2-4-8-18)28(16-23(29)30)25(31)27(17)15-19-9-5-6-10-22(19)34(32,33)21-13-11-20(26)12-14-21/h2-14H,15-16H2,1H3,(H,29,30)

Standard InChI Key:  XKOGGZRFOQUSDO-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3775455

    ---

Associated Targets(Human)

PEX16 Tbio Peroxisomal membrane protein PEX16 (26 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGDR2 Tchem G protein-coupled receptor 44 (4688 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 480.52Molecular Weight (Monoisotopic): 480.1155AlogP: 3.73#Rotatable Bonds: 7
Polar Surface Area: 98.37Molecular Species: ACIDHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 3.20CX Basic pKa: CX LogP: 3.88CX LogD: 0.43
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.41Np Likeness Score: -1.23

References

1. Buil MA, Calbet M, Castillo M, Castro J, Esteve C, Ferrer M, Forns P, González J, López S, Roberts RS, Sevilla S, Vidal B, Vidal L, Vilaseca P..  (2016)  Structure-activity relationships (SAR) and structure-kinetic relationships (SKR) of sulphone-based CRTh2 antagonists.,  113  [PMID:26922232] [10.1016/j.ejmech.2016.02.023]

Source